Therefore, searches were expanded to include community-acquired Gram-negative infections to identify additional articles relevant to economic outcomes of length of stay or cost. Study Inclusion ...

Infections by multidrug resistant organisms (MDROs) are a global health threat with a worrying increasing trend. In fragile ...

Infex Therapeutics, the Alderley Park-based anti-infectives specialist, has been awarded a £1m grant, alongside Germany’s ...

GR was a paid consultant to Cubist Pharmaceuticals on a previous project on "Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant pseudomonas aeruginosa ...

The following is a summary of “Plasma Lipopolysaccharide-Binding Protein (LBP) Is Induced in Critically Ill Females with Gram ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

Nine species (240 strains) of gram-negative bacilli were studied; 221 were freshly isolated from the urinary and intestinal tracts, wounds and abscesses. Thirteen strains of salmonella and 6 of ...

Background One in six infant deaths worldwide are caused by invasive bacterial infections, of which a substantial but unquantified proportion are caused by Gram-negative bacteria. Methods We conducted ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...